Literature DB >> 14506299

Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection.

Ashley I Bush1, Colin L Masters, Rudolph E Tanzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14506299      PMCID： PMC208731          DOI： 10.1073/pnas.2135061100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  26 in total

1.  Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma.

Authors:  A Kontush; C Berndt; W Weber; V Akopyan; S Arlt; S Schippling; U Beisiegel
Journal:  Free Radic Biol Med       Date:  2001-01-01       Impact factor: 7.376

2.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

Authors:  K Fassbender; M Simons; C Bergmann; M Stroick; D Lutjohann; P Keller; H Runz; S Kuhl; T Bertsch; K von Bergmann; M Hennerici; K Beyreuther; T Hartmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

3.  Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

Authors:  R A Cherny; J T Legg; C A McLean; D P Fairlie; X Huang; C S Atwood; K Beyreuther; R E Tanzi; C L Masters; A I Bush
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

4.  Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study.

Authors:  V Rondeau; D Commenges; H Jacqmin-Gadda; J F Dartigues
Journal:  Am J Epidemiol       Date:  2000-07-01       Impact factor: 4.897

5.  Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits.

Authors:  C C Curtain; F Ali; I Volitakis; R A Cherny; R S Norton; K Beyreuther; C J Barrow; C L Masters; A I Bush; K J Barnham
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

6.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

Authors:  C S Atwood; R C Scarpa; X Huang; R D Moir; W D Jones; D P Fairlie; R E Tanzi; A I Bush
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

7.  Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

Authors:  R A Cherny; C S Atwood; M E Xilinas; D N Gray; W D Jones; C A McLean; K J Barnham; I Volitakis; F W Fraser; Y Kim; X Huang; L E Goldstein; R D Moir; J T Lim; K Beyreuther; H Zheng; R E Tanzi; C L Masters; A I Bush
Journal:  Neuron       Date:  2001-06       Impact factor: 17.173

8.  Copper catalyzed oxidation of Alzheimer Abeta.

Authors:  C S Atwood; X Huang; A Khatri; R C Scarpa; Y S Kim; R D Moir; R E Tanzi; A E Roher; A I Bush
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2000-06       Impact factor: 1.770

9.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

Authors:  X Huang; M P Cuajungco; C S Atwood; M A Hartshorn; J D Tyndall; G R Hanson; K C Stokes; M Leopold; G Multhaup; L E Goldstein; R C Scarpa; A J Saunders; J Lim; R D Moir; C Glabe; E F Bowden; C L Masters; D P Fairlie; R E Tanzi; A I Bush
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Authors:  B Wolozin; W Kellman; P Ruosseau; G G Celesia; G Siegel
Journal:  Arch Neurol       Date:  2000-10
View more
  29 in total

Review 1.  Nanopore analysis: An emerging technique for studying the folding and misfolding of proteins.

Authors:  Claudia Madampage; Omid Tavassoly; Chris Christensen; Meena Kumari; Jeremy S Lee
Journal:  Prion       Date:  2012-04-01       Impact factor: 3.931

2.  Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-06       Impact factor: 11.205

Review 3.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

4.  Interaction of apoNeuroglobin with heme-Aβ complexes relevant to Alzheimer's disease.

Authors:  Manas Seal; Sheetal Uppal; Suman Kundu; Somdatta Ghosh Dey
Journal:  J Biol Inorg Chem       Date:  2015-02-08       Impact factor: 3.358

Review 5.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

6.  PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Authors:  Olivier Boutaud; Thomas J Montine; Lei Chang; William L Klein; John A Oates
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

7.  Inhibition of Aβ42 peptide aggregation by a binuclear ruthenium(II)-platinum(II) complex: Potential for multi-metal organometallics as anti-amyloid agents.

Authors:  Amit Kumar; Lamaryet Moody; Jason F Olaivar; Nerissa A Lewis; Rahul L Khade; Alvin A Holder; Yong Zhang; Vijayaraghavan Rangachari
Journal:  ACS Chem Neurosci       Date:  2010-08-23       Impact factor: 4.418

8.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease.

Authors:  Gang Liu; Ping Men; George Perry; Mark A Smith
Journal:  J Nanoneurosci       Date:  2009-06-01

9.  Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.

Authors:  Alicia N Minniti; Daniela L Rebolledo; Paula M Grez; Ricardo Fadic; Rebeca Aldunate; Irene Volitakis; Robert A Cherny; Carlos Opazo; Colin Masters; Ashley I Bush; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2009-01-06       Impact factor: 14.195

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.